New combo therapy aims to tackle Tough-to-Treat myeloma
NCT ID NCT05137054
First seen Jun 26, 2026 · Last updated Jul 09, 2026 · Updated 3 times
Summary
This study tests an experimental drug called linvoseltamab combined with other cancer treatments for people with multiple myeloma that has come back after previous therapy. The main goal is to see if the combinations are safe and to find the right dose. About 317 participants will be enrolled, and researchers will also check if the tumors shrink or disappear.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- linvoseltamab (also called REGN5458) plus other cancer drugs (daratumumab, carfilzomib, lenalidomide, bortezomib)
- What this could lead to
- If successful, this could lead to a new combination treatment option for patients with multiple myeloma that has returned after prior therapies.
- What could go wrong
- This is an early Phase 1b study focused on safety and dosing, so it is too soon to know if the combinations will work. Side effects from the drugs are possible, and the trial is small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Montpellier - Departement D'Hematologie
RECRUITINGMontpellier, 34295, France
-
CHU de Lille - Rue Michel Polonovski
SUSPENDEDLille, Nord, 59037, France
-
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITINGPoitiers, New Aquitaine, 86021, France
-
Centre Hospitalier Universitaire Angers
RECRUITINGAngers, 49933, France
-
Clinica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
-
Clinica Universidad de Navarra - Madrid
RECRUITINGMadrid, 28027, Spain
-
Dana Farber/Harvard Cancer Center
RECRUITINGBoston, Massachusetts, 02215, United States
-
Evangelismos General Hospital
RECRUITINGAthens, Attica, 10676, Greece
-
General Hospital of Athens Alexandra
RECRUITINGAthens, 11528, Greece
-
Hadassah Medical Center
RECRUITINGJerusalem, 91120, Israel
-
Hopital Necker
RECRUITINGParis, Île-de-France Region, 75015, France
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hospital Clinico Universitario de Santiago
RECRUITINGSantiago de Compostela, A Coruna, 15706, Spain
-
Hospital Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 08916, Spain
-
Hospital Henri Mondor
RECRUITINGCréteil, Île-de-France Region, 94000, France
-
Hospital Universitario HM Sanchinarro
RECRUITINGMadrid, 28050, Spain
-
Hospital Universitario Marques de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
-
Hospital Universitario Quiron Salud Madrid
RECRUITINGPozuelo de Alarcón, Madrid, 28223, Spain
-
Hospital Universitario Ramon y Cajal - Servicio de Psiquiatria
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Indiana University Health Simon Cancer Center
RECRUITINGIndianapolis, Indiana, 46202, United States
-
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals,
RECRUITINGBarcelona, 08908, Spain
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Nantes University Hospital
RECRUITINGNantes, Pays de la Loire Region, 44093, France
-
New York Presbyterian Hospital Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
-
Rambam Health Care Campus
RECRUITINGHaifa, 3109601, Israel
-
Saint Antoine Hospital
RECRUITINGParis, 75571, France
-
Saint Louis Hospital
RECRUITINGParis, Île-de-France Region, 75010, France
-
Scripps Clinic Torrey Pines
RECRUITINGLa Jolla, California, 92037, United States
-
Sheba Medical Center
RECRUITINGRamat Gan, Central District, 5265601, Israel
-
The Ohio State University James Cancer Hospital
RECRUITINGColumbus, Ohio, 43210, United States
-
Universitaru Hospital La Princesa
RECRUITINGMadrid, 28006, Spain
-
University Hospital and Research Institute
RECRUITINGMadrid, 28041, Spain
-
University Hospital of Salamanca
RECRUITINGSalamanca, 37007, Spain
-
University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75390, United States
-
VA Puget Sound Health Care System
RECRUITINGSeattle, Washington, 98108, United States
-
Wake Forest University Health Sciences
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Weill Cornell Medicine/New York Presbyterian Hospital
RECRUITINGNew York, New York, 10021, United States
-
Winship Cancer Institute of Emory University
RECRUITINGAtlanta, Georgia, 30004, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact